单纯疱疹眼病与VZV角膜炎患者应在初诊时常规提供HIV检测——英国眼科实践建议
Routine HIV testing in zoster eye disease
作者建议眼科医生在对疑似HZO或VZV角膜炎患者初诊时即常规提供HIV检测,无需等待微生物学确认;送检VZV拭子应自动触发HIV检测提议。文献回顾显示,一项112例HZO患者的基础眼科系列研究中26%为HIV阳性且均小于50岁。英国约4660人携带未确诊HIV感染,其中约42%为新发时已属晚期诊断。
Herpes zoster ophthalmicus (HZO) and varicella zoster virus (VZV) keratitis are common presentations to ophthalmic clinics and ophthalmologists are frequently the first and sometimes the only clinicians these patients see. Reactivation of VZV is a marker of impaired cell-mediated immunity, and herpes zoster is a long-recognised indicator condition for undiagnosed human immunodeficiency virus (HIV) [1]. National guidance is clear that an HIV test should be offered when an indicator condition is present [2, 3]. Despite this, HIV testing is rarely actioned in eye clinics, even when we hold objective microbiological confirmation of VZV reactivation in the form of a positive viral swab. We argue that HIV testing should be performed alongside VZV testing, and we set out a practical approach for the eye clinic.
Why zoster matters for Hiv
Herpes zoster is one of the indicator conditions in the HIV Indicator Diseases across Europe (HIDES) framework that underpins indicator condition-guided testing, all of which exceed the undiagnosed HIV prevalence threshold at which testing is cost-effective [1]. HZO typically occurs in older adults; however, the association is also strong in younger patients, especially in multi-dermatomal or recurrent disease. In a foundational ophthalmic series of 112 patients with HZO, 26% were HIV-positive positive and all of these were younger than 50 years, leading the authors to recommend HIV testing for every patient under 50 presenting with HZO [4]. HIV epidemiology has since changed, with a growing proportion of new and late diagnoses in older adults, so age should not be used to decide who is tested. Severe or atypical ocular complications, including acute retinal necrosis and progressive outer retinal necrosis, should also raise suspicion of underlying immunosuppression.
What the guidance says
NICE guideline NG60 recommends offering and recommending an HIV test to everyone who attends for testing or treatment, and recommends testing all adults in areas of high prevalence (a diagnosed prevalence of 2 to 5 per 1000 aged 15 to 59) and extremely high prevalence (5 or more per 1000) [3]. Many ophthalmic units serve populations within these prevalence bands. The public health case is pressing. In England, an estimated 4660 people are living with undiagnosed HIV, around two-thirds of them outside London, and roughly 42% of new diagnoses are made late, when CD4 counts have already fallen [5]. The success of opt-out testing in emergency departments, which now accounts for a meaningful share of new diagnoses, shows that routine offer of testing in secondary care identifies people who would otherwise be missed [5].
The gap in ophthalmology
There is currently no ophthalmology-specific guidance or standardised pathway for HIV testing in HZO or VZV keratitis in the UK. Where management patterns have been examined, eye care providers dominate the initial care of HZO, but the focus is antiviral treatment and ocular follow-up rather than systemic testing [6]. This gap was identified in our own clinical governance review and, we suspect, is widespread nationally. Ophthalmologists are well placed to close it by proactively offering testing at the time of diagnosis.
From clinical suspicion to diagnosis
Much of the existing literature and guidance is framed around clinical herpes zoster. In practice, ophthalmic units increasingly confirm VZV reactivation directly, through polymerase chain reaction (PCR) of a corneal, conjunctival or vesicle swab in HZO and VZV keratitis. A confirmed positive VZV provides objective evidence of reactivation at a discrete, documented point in the care pathway. The usual workflow stops at treating the eye. The result rarely prompts the question that reactivation should raise, which is whether the patient has an undiagnosed cause of immunosuppression. Rather than having to recall the patient to arrange HIV testing after a positive swab result, we suggest that it is justified to perform HIV testing at the initial appointment when there is clinical suspicion of VZV. We recommend that performing a viral swab should prompt an HIV test. HIV testing is now a routine investigation that can be offered and requested by any clinician, with a brief explanation and an opportunity for the patient to opt out. In this respect, it is no different from any other blood test requested as part of routine clinical care; patients should be informed why it is being performed, but extensive counselling or specialist expertise is not required. It is a low-cost investigation rather than an unnecessary one, and this approach may identify patients who would otherwise be missed if testing is only triggered once a positive result is confirmed.
A practical approach for the eye clinic
-
1.
Offer HIV testing in all patients with suspected HZO or VZV keratitis.
-
2.
Offer an HIV test when performing a viral swab, using a routine explanation such as: ‘One of the blood tests we do for everyone with this sort of eye condition is an HIV test, so I’ll request that today.’
-
3.
Consider implementing a pathway for HIV testing when there is a confirmed positive VZV swab within local laboratory or clinic reporting pathways.
-
4.
Know your local route for fourth-generation serology or point-of-care testing, including how the test is requested and where results are returned.
-
5.
Agree a clear pathway in advance for communicating reactive or positive results and for prompt onward referral to sexual health or infectious diseases services.
-
6.
Document that a test was offered, including when it is declined.
Conclusion
Ophthalmologists routinely diagnose, investigate and treat herpes zoster-related ocular disease. We recommend offering HIV testing at the initial presentation of suspected HZO or VZV keratitis, irrespective of age and without waiting for microbiological confirmation. Sending a VZV swab should act as an automatic prompt to offer testing. This small addition to routine practice aligns ophthalmic care with national HIV-testing objectives and may identify people who would otherwise remain undiagnosed. Presenting HIV testing as a routine component of good medical care, rather than as a judgement based on perceived risk, may also help to normalise testing and reduce stigma.
References
Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV Indicator Diseases across Europe Study). PLoS ONE. 2013;8:e52845.
Palfreeman A, Sullivan A, Rayment M, Buckley A, Burns F, Clutterbuck D, et al. British HIV Association/British Association for Sexual Health and HIV/British Infection Association adult HIV testing guidelines 2020. HIV Med. 2020;21:1–26.
National Institute for Health and Care Excellence. HIV testing: increasing uptake among people who may have undiagnosed HIV. NICE guideline NG60. London: NICE; 2016.
Sellitti TP, Huang AJ, Schiffman J, Davis JL. Association of herpes zoster ophthalmicus with acquired immunodeficiency syndrome and acute retinal necrosis. Am J Ophthalmol. 1993;116:297–301.
UK Health Security Agency. HIV testing, PrEP, new HIV diagnoses and care outcomes for people accessing HIV services in England: 2025 report. London: UKHSA; 2025.
Lu A, Sun Y, Porco TC, Arnold BF, Acharya NR. Practice patterns in the initial management of herpes zoster ophthalmicus in the United States. Cornea. 2024;43:6–12.
Funding
The authors received no specific funding for this work.
Author information
Authors and Affiliations
St. Paul’s Eye Unit, Royal Liverpool University Hospital, Liverpool, UK
Ahmed Bakr, Navid Hakim, Paul Hine, Nardine Menassa & Nima Ghadiri
Warrington & Halton NHS Foundation Trust, Warrington, UK
Ahmed Bakr
Authors
- Ahmed Bakr
- Navid Hakim
- Paul Hine
- Nardine Menassa
- Nima Ghadiri
Contributions
AB and NH devised the article, collated the relevant literature and guidance, and drafted the manuscript. PH provided senior clinical direction from the infectious diseases perspective, and NM and NG from the ophthalmology perspective. All authors critically reviewed the manuscript and approved the final version.
Corresponding author
Correspondence to Ahmed Bakr.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bakr, A., Hakim, N., Hine, P. et al. Routine HIV testing in zoster eye disease. Eye (2026). https://doi.org/10.1038/s41433-026-05042-7
Received: 22 September 2026
Revised: 03 October 2026
Accepted: 29 October 2026
Published: 18 November 2026
Version of record: 18 November 2026
DOI: https://doi.org/10.1038/s41433-026-05042-7
来源:Nature 健康护理主题 · nature.com